• OPEN AN ACCOUNT
Indian Indices
Nifty
26,046.95 148.40
(0.57%)
Sensex
84,999.79 -267.87
( -0.31%)
Bank Nifty
59,389.95 180.10
( 0.30%)
Nifty IT
38,274.75 177.75
( 0.47%)
Global Indices
Nasdaq
48,475.79 -249.23
(-0.51%)
Dow Jones
6,848.05 -73.95
(-1.07%)
Hang Seng
50,843.93 695.11
(1.39%)
Nikkei 225
9,668.36 -34.80
(-0.36%)
Forex
USD-INR
90.19 0.30
(0.34%)
EUR-INR
105.70 1.00
(0.96%)
GBP-INR
120.75 0.96
(0.80%)
JPY-INR
0.58 0.01
(0.91%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
44.97
888.1
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.2
 

omega interactive technologies ltd
Auri Grow India reports standalone net loss of Rs 0.29 crore in the September 2025 quarter
Nov 15,2025
Net loss of Auri Grow India reported to Rs 0.29 crore in the quarter ended September 2025 as against net profit of Rs 0.70 crore during the previous quarter ended September 2024. Sales declined 90.36% to Rs 8.00 crore in the quarter ended September 2025 as against Rs 83.03 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales8.0083.03 -90
OPM %-0.381.11 -
PBDT-0.240.88 PL
PBT-0.390.77 PL
NP-0.290.70 PL